TELA Bio (TELA) Income towards Parent Company (2018 - 2026)
TELA Bio's quarterly Income towards Parent Company came in at -$12.3 million in Q1 2026, down 8.96% year-on-year from -$13.5 million in Q1 2025, and down 29.83% quarter-over-quarter from -$9.5 million in Q4 2025.
TELA Bio has reported Income towards Parent Company for 9 years, with the latest figure at -$12.3 million in Q1 2026.
- For the quarter ending Q1 2026, Income towards Parent Company fell 8.96% year-over-year to -$12.3 million; the trailing twelve-month figure through Mar 2026 stood at -$40.3 million (down 706.98% YoY), and the FY2025 full-year result was -$39.2 million, down 5270.36% from the prior year.
- Income towards Parent Company for Q1 2026 stood at -$12.3 million, down from -$9.5 million in the prior quarter.
- The five-year high for Income towards Parent Company was $29.2 million in Q4 2024, with the low at -$13.6 million in Q4 2023.
- Average Income towards Parent Company over 5 years is -$8.4 million, with a median of -$10.8 million recorded in 2022.
- Year-over-year, Income towards Parent Company soared 314.7% in 2024 and tumbled 132.32% in 2025.
- Tracing TELA's Income towards Parent Company over 5 years: stood at -$10.6 million in 2022, then retreated by 28.36% to -$13.6 million in 2023, then surged by 314.7% to $29.2 million in 2024, then plunged by 132.32% to -$9.5 million in 2025, then decreased by 29.83% to -$12.3 million in 2026.
- The last three Income towards Parent Company figures came in at -$12.3 million (Q1 2026), -$9.5 million (Q4 2025), and -$8.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.27 Mn |
| Dec 31, 2025 | -9.45 Mn |
| Sep 30, 2025 | -8.60 Mn |
| Jun 30, 2025 | -9.92 Mn |
| Mar 31, 2025 | -11.26 Mn |
| Dec 31, 2024 | 29.25 Mn |
| Sep 30, 2024 | -10.37 Mn |
| Jun 30, 2024 | -12.60 Mn |
| Mar 31, 2024 | -5.66 Mn |
| Dec 31, 2023 | -13.62 Mn |
| Sep 30, 2023 | -11.52 Mn |
| Jun 30, 2023 | -11.66 Mn |
| Mar 31, 2023 | -12.50 Mn |
| Dec 31, 2022 | -10.61 Mn |
| Sep 30, 2022 | -10.52 Mn |
| Jun 30, 2022 | -11.17 Mn |
| Mar 31, 2022 | -10.76 Mn |
| Dec 31, 2021 | -8.58 Mn |
| Sep 30, 2021 | -8.14 Mn |
| Jun 30, 2021 | -8.18 Mn |
| Mar 31, 2021 | -8.16 Mn |
| Dec 31, 2020 | -7.65 Mn |
| Sep 30, 2020 | -7.76 Mn |
| Jun 30, 2020 | -6.05 Mn |
| Mar 31, 2020 | -7.38 Mn |
| Dec 31, 2019 | -6.71 Mn |
| Sep 30, 2019 | -4.76 Mn |
| Jun 30, 2019 | -5.21 Mn |
| Mar 31, 2019 | -6.09 Mn |
| Dec 31, 2018 | -6.26 Mn |
| Sep 30, 2018 | -2.83 Mn |